Lilly, Incyte, CSL among winners of EU drug recommendations this week
Seeking Alpha ·
An expert panel of the EU drug regulator, the European Medicines Agency, endorsed six new medicines and 11 label expansions for approval this week, benefiting drugmakers including Eli Lilly ( LLY ), Incyte ( INCY ), and CSL Limited ( CSLLY ) ( CMXHF ).
DYAX Investor Sentiment
Bullish (Long) 38% · Bearish (Short) 62%
275 participants
Related News
- Palantir Tops Oversold Mega Cap Tech List
- Saudi Arabia resumes oil loadings at its biggest export terminal after four-month halt
- Government Pressure Hits OpenAI Model Launch
- Apple China iPhone Sell-In Drops 19%
- Investment managers exposure index jumps to highest since December
- From models to studios: how AI video investment is evolving